“Measuring biomarkers by a simple finger prick could facilitate regular and autonomous sampling at home ... families affected ...

Diagnosis of Alzheimer's disease (AD) is currently largely based on the presence of biomarkers. This may lead to a ...

New Delhi: While early detection of Alzheimer’s disease is crucial for better outcomes, a report on Wednesday said that blood ...

Changes in the brain linked to a risk of Alzheimer's disease may also make some older adults vulnerable to financial scams, ...

A simple test that checks the levels of a certain protein in the blood could “reliably rule out” Alzheimer’s in those being ...

Lucent Diagnostics, a brand of Quanterix Corporation (NASDAQ: QTRX), has introduced LucentAD Complete, a new multi-marker blood test designed to help detect Alzheimer’s Disease (AD) in a broader range ...

A study has shone a light on one crucial supplement that may boost brain function among older adults in just a matter of ...

Find out what AI has already brought to Alzheimer's disease research and most importantly, what it can accomplish in the ...

Could the drug that's changing the weight loss industry also protect older adults against the most common form of dementia?

Data from the AscenD-LB Phase 2a trial in DLB confirm recent scientific literature indicating that plasma glial fibrillary acid protein (GFAP) is ...

The blood-borne virus - dubbed a 'silent killer' - often progresses so slowly it can largely go unnoticed for decades ...

Approximately 982,000 people are living with Alzheimer's disease in the UK, according to the Alzheimer's Society. This is forecasted to rise to a worrying 1.4million by 2040.